Landing Point Financial Group »

4d Molecular Therapeutics In shares owned by Landing Point Financial Group

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Landing Point Financial Group from 13F filings

Historical chart of Landing Point Financial Group investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Landing Point Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Landing Point Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $143k 19k 7.50

More positions owned by Landing Point Financial Group

Ishares Core S&p 500 Etf Etf (IVV)
Fidelity High Dividend Etf Etf (FDVV)
Ishares Ultra Short Duration Bond Active Etf Etf (ICSH)
Ishares Aaa Clo Active Etf Etf (CLOA)
Apple Stock (AAPL)
Fidelity Enhanced Small Cap Etf Etf (FESM)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Msci Eafe Value Etf Etf (EFV)
Nvidia Corporation Stock (NVDA)
Ishares Msci Emerging Markets Etf Etf (EEM)
Ishares Broad Usd Investment Grade Corporate Bond Etf Etf (USIG)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Landing Point Financial Group

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In